Cargando…
Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies
Triple-negative breast cancer (TNBC) is a heterogeneous subtype of tumors that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. The mainstay of treatment remains chemotherapy, but the therapeutic outcome remains inadequate. This paper investigates the potential...
Autores principales: | El-Deeb, Ibrahim M., Pittala, Valeria, Eltayeb, Diab, Greish, Khaled |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227162/ https://www.ncbi.nlm.nih.gov/pubmed/34207832 http://dx.doi.org/10.3390/molecules26123532 |
Ejemplares similares
-
Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections
por: Virzì, Nicola F., et al.
Publicado: (2023) -
Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
por: Bahman, Fatemah, et al.
Publicado: (2021) -
Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer
por: Greish, Khaled, et al.
Publicado: (2018) -
In Vivo Evaluation of Anti-Nociceptive Effects of Silver Nanoparticles
por: Morsi, Shereen, et al.
Publicado: (2022) -
Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
por: Alimoradi, Houman, et al.
Publicado: (2018)